Jessica Stoodley

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Ejection Fraction

Duchenne Muscular Dystrophy

Top Venues

International journal of molecular sciences

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anna J Kordala, Jessica Stoodley, Nina Ahlskog, Muhammad Hanifi, Antonio Garcia-Guerra, Amarjit Bhomra, Wooi Fang Lim, Lyndsay M Murray, Kevin Talbot, Suzan M Hammond, Matthew Ja Wood, Carlo Rinaldi
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. EMBO molecular medicine (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)
Jessica Stoodley, Francisco Vallejo-Bedia, David Seone-Miraz, Manuel Debasa-Mouce, Matthew J A Wood, Miguel A Varela
Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. International journal of molecular sciences 24 (3) (2023)